Fundraising Fox

Hoth Therapeutics

New York, US · Founded 2017 · Nevada corporation

Biotech

Founders & leadership

VM
VADIM MATSNamed on SEC filing
RK
ROBB KNIENamed on SEC filing
KR
KENNETH RICENamed on SEC filing
AH
ANTHONY HAYESNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$33.7M disclosed across 6 rounds · 2017–2023

▶$10MraisedJan 2023 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Wayne LinsleyDirector
  • David SarnoffDirector
  • Robb KnieExecutive Officer, Director
  • Graig SpringerDirector
  • Jeff PavellDirector
  • David BrionesExecutive Officer
Offering amount
$10M
Amount sold
$10M
Sales commissions
$700K
Placement agents
H.C. Wainwright & Co., LLC
First sale
Jan 2023
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedMar 2021 · 13 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robb KnieExecutive Officer, Director
  • David BrionesExecutive Officer
  • Stefanie JohnsExecutive Officer
  • David SarnoffDirector
  • Vadim MatsDirector
  • Graig SpringerDirector
  • Wayne LinsleyDirector
Offering amount
$15M
Amount sold
$15M
Sales commissions
$1.1M
Placement agents
H.C. Wainwright & Co., LLC
First sale
Mar 2021
Incorporated
Corporation, Nevada, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJan 2021 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David SarnoffDirector
  • Stefanie JohnsExecutive Officer
  • David BrionesExecutive Officer
  • Wayne LinsleyDirector
  • Graig SpringerDirector
  • Vadim MatsDirector
  • Robb KnieExecutive Officer, Director
Offering amount
$5M
Amount sold
$5M
Sales commissions
$350K
Placement agents
The Benchmark Company, LLC
First sale
Jan 2021
Incorporated
Corporation, Nevada, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedAug 2019 · 53 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robb KnieExecutive Officer, Director
  • Vadim MatsDirector
  • Kenneth RiceDirector
  • Anthony HayesDirector
  • David B. SarnoffDirector
  • David BrionesExecutive Officer
Offering amount
$5M
Amount sold
$2M
Minimum investment
$10K
Sales commissions
$294.5K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Aug 2019
Incorporated
Corporation, Nevada, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedNov 2017 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Anthony HayesDirector
  • Robb KnieExecutive Officer, Director, Promoter
  • Vadim MatsDirector
  • Kenneth RiceDirector
Offering amount
$5M
Amount sold
$1M
Minimum investment
$10K
Sales commissions
$650K
Proceeds to insiders
$150K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Oct 2017
Incorporated
Corporation, Nevada, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$675KraisedJul 2017 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • VADIM MATSDirector
  • ROBB KNIEExecutive Officer, Promoter
  • KENNETH RICEDirector
  • ANTHONY HAYESDirector
Offering amount
$675K
Amount sold
$675K
Minimum investment
$675K
First sale
Jun 2017
Incorporated
Corporation, Nevada, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Hoth Therapeutics raised?
Hoth Therapeutics has disclosed $33.7M raised across 6 rounds.
Where is Hoth Therapeutics headquartered?
Hoth Therapeutics is headquartered in New York, US.